The Valley Desk

ArticleThe oncologistPublished

Incidence and outcomes of FGFR inhibitor-associated retinopathy of patients treated with oral erdafitinib across the clinical trial program

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
The oncologist
Published
Subject terms
Humans; Retinal Diseases; Pyrazoles; Quinoxalines; Receptors, Fibroblast Growth Factor; Protein Kinase Inhibitors; Administration, Oral; Aged; Middle Aged; Female; Male; Fibroblast growth factor receptors
PubMed ID
42127981
PubMed Central ID
PMC13293072
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal